The Global Hematology Diagnostics Market is likely to derive growth from the increasing incidence of blood disorders. According to a report by Fortune Business Insights, titled “Hematology Diagnostics Market Size, Share and Global Trend By Type (Instruments, Consumables), By End User (Diagnostic Centers, Hospitals and Clinics, Academic and Research Institutions), and Geography Forecast till 2026,” the market will benefit from increasing product launches in the coming years.
Get Sample PDF [email protected]
Some of the Main Key Players Covered in the Report
- Beckman Coulter
- HORIBA, Ltd.
- Sysmex Corporation
- Instrumentation Laboratory, A Werfen Company
- Siemens Healthineers
- Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories
- HemoCue AB
Hematology refers to disorders associated with blood and blood-forming organs. The severity of hematology disorders due to the high dependency of the human body on blood and blood cells has led to a growing emphasis on efficient treatment options. The increasing emphasis on research and development of new drugs and therapies will have a positive impact on the global hematology diagnostics market.
Market to Benefit from the Launch of Several Enhanced Diagnostic Systems
The increasing prevalence of hematology disorders has led to several product innovations and also created an increase in product launches in recent years. The market is likely to benefit from recent product launches and is set to derive growth from product innovations in the foreseeable future.
In 2018, Abbott announced the launch of its Alinity h-series Integrated Hematology System aimed at enhanced hematology analysis. Abbott’s latest received the CE mark in the same year and Fortune Business Insights predicts that this product will have a positive impact on the global market. Another notable product that caught the eyes of several investors was Horiba’s D-Dimer hematology reagent, aimed at the betterment of its hemostasis instruments.
The report encompasses several products similar to the latest products by Abbot and Horiba and gauges their impact on the global hematology diagnostics market.
North America and Europe Among the Leading Regions in the Global Market
The report includes segmentation of the global hematology diagnostics market based on several aspects such as product type, end user, and regional demographics. Among all regions, Fortune Business Insights predicts that the market will see comparatively high growth in North America and Europe. The increasing prevalence of blood disorders in these particular regions has favored growth in the aforementioned regional markets.
Additionally, several ongoing research and development (R&D) activities towards the development of advanced diagnostic methods will contribute to the growth of the hematology diagnostic market in North America as well as Europe. Having said that, Asia Pacific is likely to witness considerable growth in the coming years due to the enhanced healthcare systems in regions such as Japan and China.
More Trending Topics from Future Business Insights: